{"id": "article-25619_0", "title": "Necrobiosis Lipoidica -- Continuing Education Activity", "content": "Necrobiosis lipoidica (NL) is a rare, chronic, and idiopathic granulomatous disease of collagen degeneration. It has an associated risk of ulceration and is classically associated with diabetes mellitus, usually type 1. There is a thickening of the walls of the blood vessels and deposition of fat. The major complication of the disease is the formation of an ulcer, mainly occurring after trauma. Uncommonly, infections can also occur. Moreover, if necrobiosis lipoidica becomes chronic, it may rarely turn into squamous cell carcinoma. The cause of necrobiosis lipoidica remains unknown. However, vascular disturbance involving immune complex deposition or microangiopathic changes leading to collagen degeneration has been the most common theory. This activity reviews the pathophysiology of necrobiosis lipoidica and highlights the role of the interprofessional team in ensuring the best patient outcomes.", "contents": "Necrobiosis Lipoidica -- Continuing Education Activity. Necrobiosis lipoidica (NL) is a rare, chronic, and idiopathic granulomatous disease of collagen degeneration. It has an associated risk of ulceration and is classically associated with diabetes mellitus, usually type 1. There is a thickening of the walls of the blood vessels and deposition of fat. The major complication of the disease is the formation of an ulcer, mainly occurring after trauma. Uncommonly, infections can also occur. Moreover, if necrobiosis lipoidica becomes chronic, it may rarely turn into squamous cell carcinoma. The cause of necrobiosis lipoidica remains unknown. However, vascular disturbance involving immune complex deposition or microangiopathic changes leading to collagen degeneration has been the most common theory. This activity reviews the pathophysiology of necrobiosis lipoidica and highlights the role of the interprofessional team in ensuring the best patient outcomes."}
{"id": "article-25619_1", "title": "Necrobiosis Lipoidica -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of necrobiosis lipoidica. Review the presentation of necrobiosis lipoidica. Summarize the treatment of necrobiosis lipoidica. Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by necrobiosis lipoidica. Access free multiple choice questions on this topic.", "contents": "Necrobiosis Lipoidica -- Continuing Education Activity. Objectives: Describe the pathophysiology of necrobiosis lipoidica. Review the presentation of necrobiosis lipoidica. Summarize the treatment of necrobiosis lipoidica. Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by necrobiosis lipoidica. Access free multiple choice questions on this topic."}
{"id": "article-25619_2", "title": "Necrobiosis Lipoidica -- Introduction", "content": "Necrobiosis lipoidica (NL) is a rare, chronic, and idiopathic granulomatous disease of collagen degeneration. It has an associated risk of ulceration and is classically associated with diabetes mellitus, usually type 1.\u00a0There is a thickening of the blood vessels' walls and fat deposition. The major\u00a0complication of the disease is the formation of an ulcer, mainly occurring after trauma. Uncommonly, infections can also occur. Moreover, if\u00a0necrobiosis lipoidica becomes chronic, it may rarely turn into squamous cell carcinoma. [1] [2] [3] Necrobiosis lipoidica was first\u00a0mentioned as\u00a0dermatitis atrophicans lipoidica diabetica in 1929 by Oppenheim. However, in 1932,\u00a0Urbach\u00a0renamed the disease necrobiosis lipoidica diabeticorum (NLD).", "contents": "Necrobiosis Lipoidica -- Introduction. Necrobiosis lipoidica (NL) is a rare, chronic, and idiopathic granulomatous disease of collagen degeneration. It has an associated risk of ulceration and is classically associated with diabetes mellitus, usually type 1.\u00a0There is a thickening of the blood vessels' walls and fat deposition. The major\u00a0complication of the disease is the formation of an ulcer, mainly occurring after trauma. Uncommonly, infections can also occur. Moreover, if\u00a0necrobiosis lipoidica becomes chronic, it may rarely turn into squamous cell carcinoma. [1] [2] [3] Necrobiosis lipoidica was first\u00a0mentioned as\u00a0dermatitis atrophicans lipoidica diabetica in 1929 by Oppenheim. However, in 1932,\u00a0Urbach\u00a0renamed the disease necrobiosis lipoidica diabeticorum (NLD)."}
{"id": "article-25619_3", "title": "Necrobiosis Lipoidica -- Introduction", "content": "In 1935, the first case was reported by Goldsmith in a nondiabetic patient. Subsequently, more cases of NLD were\u00a0described by Meischer and Leder in nondiabetic patients in 1948. In 1960, Rollins and Winkelmann also published about\u00a0NLD in nondiabetic patients. Hence,\u00a0the suggestion\u00a0to exclude diabetes from the name of the disease was put forward. [4] Today, a broader term, necrobiosis lipoidica, encompasses all patients with the same clinical lesions without considering the presence or absence of diabetes.", "contents": "Necrobiosis Lipoidica -- Introduction. In 1935, the first case was reported by Goldsmith in a nondiabetic patient. Subsequently, more cases of NLD were\u00a0described by Meischer and Leder in nondiabetic patients in 1948. In 1960, Rollins and Winkelmann also published about\u00a0NLD in nondiabetic patients. Hence,\u00a0the suggestion\u00a0to exclude diabetes from the name of the disease was put forward. [4] Today, a broader term, necrobiosis lipoidica, encompasses all patients with the same clinical lesions without considering the presence or absence of diabetes."}
{"id": "article-25619_4", "title": "Necrobiosis Lipoidica -- Etiology", "content": "The cause of necrobiosis lipoidica remains unknown. However, the most common theory is vascular disturbance involving immune complex deposition or microangiopathic changes leading to collagen degeneration. [5] Following are some theories that have been proposed over time about the etiology of the disease:", "contents": "Necrobiosis Lipoidica -- Etiology. The cause of necrobiosis lipoidica remains unknown. However, the most common theory is vascular disturbance involving immune complex deposition or microangiopathic changes leading to collagen degeneration. [5] Following are some theories that have been proposed over time about the etiology of the disease:"}
{"id": "article-25619_5", "title": "Necrobiosis Lipoidica -- Etiology -- Diabetic Microangiopathy", "content": "As there exists a strong association between diabetes and necrobiosis lipoidica, several studies have emphasized diabetic microangiopathy to be the prime etiological factor. [6] This can be further supported by the fact that the effects of diabetes on the ocular and renal vasculature are comparable to the vascular changes observed in necrobiosis lipoidica. In addition, glycoprotein deposition has often been described in blood vessel walls in cases of diabetic microangiopathy. Similarly, a glycoprotein deposition is observed in necrobiosis lipoidica.", "contents": "Necrobiosis Lipoidica -- Etiology -- Diabetic Microangiopathy. As there exists a strong association between diabetes and necrobiosis lipoidica, several studies have emphasized diabetic microangiopathy to be the prime etiological factor. [6] This can be further supported by the fact that the effects of diabetes on the ocular and renal vasculature are comparable to the vascular changes observed in necrobiosis lipoidica. In addition, glycoprotein deposition has often been described in blood vessel walls in cases of diabetic microangiopathy. Similarly, a glycoprotein deposition is observed in necrobiosis lipoidica."}
{"id": "article-25619_6", "title": "Necrobiosis Lipoidica -- Etiology -- Immunoglobulins, Complement, and Fibrinogen", "content": "It has been described that\u00a0the deposition of immunoglobulins, C3 - the 3rd component of complement, and fibrinogen in the walls of the vasculature results in the development of necrobiosis lipoidica. [7] Some argue that an antibody-mediated\u00a0reaction may start the blood vessel changes causing necrobiosis in necrobiosis lipoidica.", "contents": "Necrobiosis Lipoidica -- Etiology -- Immunoglobulins, Complement, and Fibrinogen. It has been described that\u00a0the deposition of immunoglobulins, C3 - the 3rd component of complement, and fibrinogen in the walls of the vasculature results in the development of necrobiosis lipoidica. [7] Some argue that an antibody-mediated\u00a0reaction may start the blood vessel changes causing necrobiosis in necrobiosis lipoidica."}
{"id": "article-25619_7", "title": "Necrobiosis Lipoidica -- Etiology -- Abnormal Collagen", "content": "Additionally,\u00a0it has been theorized that the etiology of\u00a0necrobiosis lipoidica is associated with\u00a0abnormal collagen. It is well-recognized that abnormal collagen fibrils\u00a0are responsible for diabetes-related end-organ damage and expedited aging. In diabetes, collagen cross-linking increases as a result of elevated lysyl oxidase levels.\u00a0This increase in collagen cross-linking could cause the thickening of the basement membrane in necrobiosis lipoidica.", "contents": "Necrobiosis Lipoidica -- Etiology -- Abnormal Collagen. Additionally,\u00a0it has been theorized that the etiology of\u00a0necrobiosis lipoidica is associated with\u00a0abnormal collagen. It is well-recognized that abnormal collagen fibrils\u00a0are responsible for diabetes-related end-organ damage and expedited aging. In diabetes, collagen cross-linking increases as a result of elevated lysyl oxidase levels.\u00a0This increase in collagen cross-linking could cause the thickening of the basement membrane in necrobiosis lipoidica."}
{"id": "article-25619_8", "title": "Necrobiosis Lipoidica -- Etiology -- Impaired Neutrophil Migration", "content": "It also has been observed that there could be defective neutrophil migration causing an increase in the number of macrophages, possibly justifying the formation of granuloma in necrobiosis lipoidica. [8]", "contents": "Necrobiosis Lipoidica -- Etiology -- Impaired Neutrophil Migration. It also has been observed that there could be defective neutrophil migration causing an increase in the number of macrophages, possibly justifying the formation of granuloma in necrobiosis lipoidica. [8]"}
{"id": "article-25619_9", "title": "Necrobiosis Lipoidica -- Etiology -- Tumor Necrosis Factor (TNF)\u2013Alpha", "content": "Tumor necrosis factor (TNF)\u2013alpha has been observed to play a potentially crucial role in granulomatous diseases such as necrobiosis lipoidica and disseminated granuloma. [9] It is raised\u00a0in the sera and skin of the patients suffering from these conditions.", "contents": "Necrobiosis Lipoidica -- Etiology -- Tumor Necrosis Factor (TNF)\u2013Alpha. Tumor necrosis factor (TNF)\u2013alpha has been observed to play a potentially crucial role in granulomatous diseases such as necrobiosis lipoidica and disseminated granuloma. [9] It is raised\u00a0in the sera and skin of the patients suffering from these conditions."}
{"id": "article-25619_10", "title": "Necrobiosis Lipoidica -- Etiology -- Tumor Necrosis Factor (TNF)\u2013Alpha", "content": "A study conducted by Hammer et al. on 64,133 patients who have type 1 diabetes observed that those with necrobiosis lipoidica were more likely to have worse metabolic control, a lengthier course\u00a0of diabetes, and an increased need for insulin doses as opposed to the other patients. Additionally, a correlation was noted between celiac disease and necrobiosis lipoidica, and it was observed that a larger percentage of patients having necrobiosis lipoidica had raised levels of thyroid antibodies. [7]", "contents": "Necrobiosis Lipoidica -- Etiology -- Tumor Necrosis Factor (TNF)\u2013Alpha. A study conducted by Hammer et al. on 64,133 patients who have type 1 diabetes observed that those with necrobiosis lipoidica were more likely to have worse metabolic control, a lengthier course\u00a0of diabetes, and an increased need for insulin doses as opposed to the other patients. Additionally, a correlation was noted between celiac disease and necrobiosis lipoidica, and it was observed that a larger percentage of patients having necrobiosis lipoidica had raised levels of thyroid antibodies. [7]"}
{"id": "article-25619_11", "title": "Necrobiosis Lipoidica -- Epidemiology", "content": "Necrobiosis lipoidica has an increased prevalence in individuals with diabetes, although this association is currently challengable. The incidence among people with diabetes is only 0.3% to 1.2%. Necrobiosis lipoidica\u00a0precedes diabetes in up to 14%\u00a0and appears simultaneously in up to 24%, and occurs after diabetes is diagnosed in 62% of cases. There is no proven connection between the level of glycemic control and the likelihood of developing necrobiosis lipoidica.", "contents": "Necrobiosis Lipoidica -- Epidemiology. Necrobiosis lipoidica has an increased prevalence in individuals with diabetes, although this association is currently challengable. The incidence among people with diabetes is only 0.3% to 1.2%. Necrobiosis lipoidica\u00a0precedes diabetes in up to 14%\u00a0and appears simultaneously in up to 24%, and occurs after diabetes is diagnosed in 62% of cases. There is no proven connection between the level of glycemic control and the likelihood of developing necrobiosis lipoidica."}
{"id": "article-25619_12", "title": "Necrobiosis Lipoidica -- Epidemiology", "content": "Although it may present in healthy individuals with no underlying disease, other commonly associated conditions are thyroid disorders and inflammatory diseases, such as Crohn disease, ulcerative colitis, rheumatoid arthritis, and sarcoidosis. In one series, researchers found surprisingly lower rates of arterial hypertension than in the standard population, while obesity and fatty acid disorders were at a standard rate. No evidence for the induction of necrobiosis lipoidica\u00a0by infection or underlying malignancies was found among those patients. There appears to be a predominance of 77% in females. [10] Also, the onset in women is younger than in men. Necrobiosis lipoidica\u00a0has an average age of onset between 30 and 40 years.", "contents": "Necrobiosis Lipoidica -- Epidemiology. Although it may present in healthy individuals with no underlying disease, other commonly associated conditions are thyroid disorders and inflammatory diseases, such as Crohn disease, ulcerative colitis, rheumatoid arthritis, and sarcoidosis. In one series, researchers found surprisingly lower rates of arterial hypertension than in the standard population, while obesity and fatty acid disorders were at a standard rate. No evidence for the induction of necrobiosis lipoidica\u00a0by infection or underlying malignancies was found among those patients. There appears to be a predominance of 77% in females. [10] Also, the onset in women is younger than in men. Necrobiosis lipoidica\u00a0has an average age of onset between 30 and 40 years."}
{"id": "article-25619_13", "title": "Necrobiosis Lipoidica -- Epidemiology", "content": "A\u00a0study by Hashemi et al. observed that in patients\u00a0having necrobiosis lipoidica, those with diabetes had a median age of 45 years as opposed to 52 years in patients who were not suffering from diabetes. [11]", "contents": "Necrobiosis Lipoidica -- Epidemiology. A\u00a0study by Hashemi et al. observed that in patients\u00a0having necrobiosis lipoidica, those with diabetes had a median age of 45 years as opposed to 52 years in patients who were not suffering from diabetes. [11]"}
{"id": "article-25619_14", "title": "Necrobiosis Lipoidica -- Epidemiology", "content": "Erfurt-Berge et al. carried out a retrospective study on 100 patients having necrobiosis lipoidica and found that female sex and middle age were characteristic in patients with the condition. The investigators also\u00a0published that ulceration, which was seen in 33% of patients, was most prevalent in men and in patients suffering from diabetes mellitus, and thyroid problems occurred in 15% of all patients. [12]", "contents": "Necrobiosis Lipoidica -- Epidemiology. Erfurt-Berge et al. carried out a retrospective study on 100 patients having necrobiosis lipoidica and found that female sex and middle age were characteristic in patients with the condition. The investigators also\u00a0published that ulceration, which was seen in 33% of patients, was most prevalent in men and in patients suffering from diabetes mellitus, and thyroid problems occurred in 15% of all patients. [12]"}
{"id": "article-25619_15", "title": "Necrobiosis Lipoidica -- Pathophysiology", "content": "An\u00a0immunologically\u00a0mediated vascular disease has been suggested as the primary cause of the altered collagen. The most common vascular abnormalities seen in necrobiosis lipoidica\u00a0lesions are thickening of the vessel walls, fibrosis, and endothelial proliferation leading to occlusion in the deeper dermis, especially in patients with\u00a0diabetes. Deposition of fibrin, IgM, and C3 at the dermo-epidermal junction of blood vessels has been shown in immunofluorescence studies. [13]", "contents": "Necrobiosis Lipoidica -- Pathophysiology. An\u00a0immunologically\u00a0mediated vascular disease has been suggested as the primary cause of the altered collagen. The most common vascular abnormalities seen in necrobiosis lipoidica\u00a0lesions are thickening of the vessel walls, fibrosis, and endothelial proliferation leading to occlusion in the deeper dermis, especially in patients with\u00a0diabetes. Deposition of fibrin, IgM, and C3 at the dermo-epidermal junction of blood vessels has been shown in immunofluorescence studies. [13]"}
{"id": "article-25619_16", "title": "Necrobiosis Lipoidica -- Pathophysiology", "content": "The concentration of collagen decreases in necrobiosis lipoidica, and electron microscopy shows a loss of the cross-striations of collagen fibrils and an important variation in the diameter of individual fibrils. Fibroblasts cultured from necrobiosis lipoidica\u00a0synthesize less collagen than their counterparts from the unaffected skin. [14] Granuloma formation has been thought to occur as a result of defective neutrophil migration allowing macrophages to take on the neutrophil role and accumulate with subsequent granuloma formation.", "contents": "Necrobiosis Lipoidica -- Pathophysiology. The concentration of collagen decreases in necrobiosis lipoidica, and electron microscopy shows a loss of the cross-striations of collagen fibrils and an important variation in the diameter of individual fibrils. Fibroblasts cultured from necrobiosis lipoidica\u00a0synthesize less collagen than their counterparts from the unaffected skin. [14] Granuloma formation has been thought to occur as a result of defective neutrophil migration allowing macrophages to take on the neutrophil role and accumulate with subsequent granuloma formation."}
{"id": "article-25619_17", "title": "Necrobiosis Lipoidica -- Histopathology", "content": "Histopathologically biopsy specimens from the palpable inflammatory border reveal scattered palisaded and interstitial granulomatous dermatitis with layered tiers of granulomatous inflammation parallel to the skin surface involving the entire dermis and extending into the subcutaneous fat septae. The epidermis is normal or atrophic. Focal loss of elastic tissue can be demonstrated in areas of connective tissue sclerosis. There is no significant mucin deposition in the center of the palisading granulomas, in contrast\u00a0with granuloma annulare.", "contents": "Necrobiosis Lipoidica -- Histopathology. Histopathologically biopsy specimens from the palpable inflammatory border reveal scattered palisaded and interstitial granulomatous dermatitis with layered tiers of granulomatous inflammation parallel to the skin surface involving the entire dermis and extending into the subcutaneous fat septae. The epidermis is normal or atrophic. Focal loss of elastic tissue can be demonstrated in areas of connective tissue sclerosis. There is no significant mucin deposition in the center of the palisading granulomas, in contrast\u00a0with granuloma annulare."}
{"id": "article-25619_18", "title": "Necrobiosis Lipoidica -- Histopathology", "content": "Necrobiosis lipoidica\u00a0demonstrates interstitial and palisaded granuloma formation, including subcutaneous layers and dermis. The granulomas are organized in a layered\u00a0manner and are admixed with patches of collagen degeneration. The granulomas are comprised of histiocytes, lymphocytes, plasma cells, and eosinophils. A decrease in the number of dermal nerves is another feature of necrobiosis lipoidica. The prime findings on histopathology are\u00a0endothelial cell swelling and thickening of the blood vessel walls from the middle to deep dermis, also a characteristic of diabetic microangiopathy. Direct immunofluorescence microscopy shows IgM, IgA, fibrinogen, and\u00a0C3 in the blood vessels\u00a0causing vascular thickening. [15]", "contents": "Necrobiosis Lipoidica -- Histopathology. Necrobiosis lipoidica\u00a0demonstrates interstitial and palisaded granuloma formation, including subcutaneous layers and dermis. The granulomas are organized in a layered\u00a0manner and are admixed with patches of collagen degeneration. The granulomas are comprised of histiocytes, lymphocytes, plasma cells, and eosinophils. A decrease in the number of dermal nerves is another feature of necrobiosis lipoidica. The prime findings on histopathology are\u00a0endothelial cell swelling and thickening of the blood vessel walls from the middle to deep dermis, also a characteristic of diabetic microangiopathy. Direct immunofluorescence microscopy shows IgM, IgA, fibrinogen, and\u00a0C3 in the blood vessels\u00a0causing vascular thickening. [15]"}
{"id": "article-25619_19", "title": "Necrobiosis Lipoidica -- Histopathology", "content": "A study by Ramadan et al. observed that cutaneous sarcoidosis could be differentiated from necrobiotic granulomas with the help of dermoscopy. They found that cutaneous sarcoidosis\u00a0varies dermoscopically from necrobiotic granulomas due to the presence of a pink homogenous background,\u00a0white scarlike depigmentation, translucent orange regions, and fine white scales. [16]", "contents": "Necrobiosis Lipoidica -- Histopathology. A study by Ramadan et al. observed that cutaneous sarcoidosis could be differentiated from necrobiotic granulomas with the help of dermoscopy. They found that cutaneous sarcoidosis\u00a0varies dermoscopically from necrobiotic granulomas due to the presence of a pink homogenous background,\u00a0white scarlike depigmentation, translucent orange regions, and fine white scales. [16]"}
{"id": "article-25619_20", "title": "Necrobiosis Lipoidica -- History and Physical", "content": "Necrobiosis lipoidica is characterized by yellow-brown, atrophic, telangiectatic plaques with an elevated violaceous rim, typically present in the pretibial surface. Less typical anatomic locations include the upper extremities, face, and scalp, where lesions may be more straight or wavy and are less weakened.", "contents": "Necrobiosis Lipoidica -- History and Physical. Necrobiosis lipoidica is characterized by yellow-brown, atrophic, telangiectatic plaques with an elevated violaceous rim, typically present in the pretibial surface. Less typical anatomic locations include the upper extremities, face, and scalp, where lesions may be more straight or wavy and are less weakened."}
{"id": "article-25619_21", "title": "Necrobiosis Lipoidica -- History and Physical", "content": "Lesions usually begin as small, firm, red-brown papules that gradually enlarge and then develop central epidermal atrophy. Ulceration occurs in approximately a third of lesions, usually following minor trauma. The plaques are usually multiple and bilateral. These lesions can Koebnerize if they are traumatized. [17] Therefore, surgical treatments represent a challenge.", "contents": "Necrobiosis Lipoidica -- History and Physical. Lesions usually begin as small, firm, red-brown papules that gradually enlarge and then develop central epidermal atrophy. Ulceration occurs in approximately a third of lesions, usually following minor trauma. The plaques are usually multiple and bilateral. These lesions can Koebnerize if they are traumatized. [17] Therefore, surgical treatments represent a challenge."}
{"id": "article-25619_22", "title": "Necrobiosis Lipoidica -- History and Physical", "content": "Skin lesions in classic necrobiosis lipoidica start as 1 to 3 mm, well-demarcated papules that expand to become plaques with more-indurated borders and waxy centers. In\u00a0the beginning, these plaques are red to brown but progress to become more yellow, shiny, and atrophic. (As shown in the image)", "contents": "Necrobiosis Lipoidica -- History and Physical. Skin lesions in classic necrobiosis lipoidica start as 1 to 3 mm, well-demarcated papules that expand to become plaques with more-indurated borders and waxy centers. In\u00a0the beginning, these plaques are red to brown but progress to become more yellow, shiny, and atrophic. (As shown in the image)"}
{"id": "article-25619_23", "title": "Necrobiosis Lipoidica -- History and Physical", "content": "The disease course appears more severe in men as they have a higher likelihood of ulceration in their lesions, reported in 58% of males vs. 15% of females. Decreased sensation to pinprick and fine touch, hypohidrosis, and partial alopecia can be found within NL plaques. Rare reports show squamous cell carcinoma\u00a0developing within lesions of NL. Some patients may report reduced sensation or sweat over these lesions.", "contents": "Necrobiosis Lipoidica -- History and Physical. The disease course appears more severe in men as they have a higher likelihood of ulceration in their lesions, reported in 58% of males vs. 15% of females. Decreased sensation to pinprick and fine touch, hypohidrosis, and partial alopecia can be found within NL plaques. Rare reports show squamous cell carcinoma\u00a0developing within lesions of NL. Some patients may report reduced sensation or sweat over these lesions."}
{"id": "article-25619_24", "title": "Necrobiosis Lipoidica -- Evaluation", "content": "Although the diagnosis often is based on clinical examination, a biopsy should be performed to differentiate necrobiosis lipoidica\u00a0from conditions with similar clinical appearances, including granuloma annulare and necrobiotic xanthogranuloma.", "contents": "Necrobiosis Lipoidica -- Evaluation. Although the diagnosis often is based on clinical examination, a biopsy should be performed to differentiate necrobiosis lipoidica\u00a0from conditions with similar clinical appearances, including granuloma annulare and necrobiotic xanthogranuloma."}
{"id": "article-25619_25", "title": "Necrobiosis Lipoidica -- Evaluation", "content": "If there is a concern for venous disease or peripheral arterial disease, further studies should be considered. Baseline blood work should include fasting blood glucose or glycosylated hemoglobin to screen for diabetes or assess glycemic control in patients known to have diabetes. If these are not diagnostic, they should be repeated on a yearly basis, as necrobiosis lipoidica\u00a0can be the first presentation of diabetes. Dermoscopy reveals yellow structureless background, white linear streaks, and linear\u00a0vessels with uniform branching.", "contents": "Necrobiosis Lipoidica -- Evaluation. If there is a concern for venous disease or peripheral arterial disease, further studies should be considered. Baseline blood work should include fasting blood glucose or glycosylated hemoglobin to screen for diabetes or assess glycemic control in patients known to have diabetes. If these are not diagnostic, they should be repeated on a yearly basis, as necrobiosis lipoidica\u00a0can be the first presentation of diabetes. Dermoscopy reveals yellow structureless background, white linear streaks, and linear\u00a0vessels with uniform branching."}
{"id": "article-25619_26", "title": "Necrobiosis Lipoidica -- Evaluation", "content": "The differential diagnosis includes mainly granuloma annulare, necrobiotic xanthogranuloma, sarcoidosis, diabetic dermopathy, and lipodermatosclerosis. Lesions of granuloma annulare and sarcoidosis generally do not exhibit the same degree of atrophy, telangiectasias, or yellow-brown color. Additionally, the appearance of lipids and decreased amount of mucin in necrobiosis lipoidica\u00a0helps to differentiate from granuloma annulare. [18]", "contents": "Necrobiosis Lipoidica -- Evaluation. The differential diagnosis includes mainly granuloma annulare, necrobiotic xanthogranuloma, sarcoidosis, diabetic dermopathy, and lipodermatosclerosis. Lesions of granuloma annulare and sarcoidosis generally do not exhibit the same degree of atrophy, telangiectasias, or yellow-brown color. Additionally, the appearance of lipids and decreased amount of mucin in necrobiosis lipoidica\u00a0helps to differentiate from granuloma annulare. [18]"}
{"id": "article-25619_27", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "No treatment has proven to be effective in necrobiosis lipoidica. In patients with diabetes mellitus, control of blood glucose usually does not significantly affect the course. In the absence of ulceration or symptoms, it is reasonable not to treat necrobiosis lipoidica, given that up to 17% of lesions may resolve spontaneously. Compression therapy controls edema and promotes healing in patients with associated venous disease or lymphedema. [19] [11] [20]", "contents": "Necrobiosis Lipoidica -- Treatment / Management. No treatment has proven to be effective in necrobiosis lipoidica. In patients with diabetes mellitus, control of blood glucose usually does not significantly affect the course. In the absence of ulceration or symptoms, it is reasonable not to treat necrobiosis lipoidica, given that up to 17% of lesions may resolve spontaneously. Compression therapy controls edema and promotes healing in patients with associated venous disease or lymphedema. [19] [11] [20]"}
{"id": "article-25619_28", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "When ulcerations are present, proper wound care principles are essential. First-line therapy includes potent topical corticosteroids for early lesions and intralesional corticosteroids injected into the active borders of established lesions. For inactive, atrophic lesions, topical steroids should be avoided as they may exacerbate the atrophy and increase the risk of new ulcerations.", "contents": "Necrobiosis Lipoidica -- Treatment / Management. When ulcerations are present, proper wound care principles are essential. First-line therapy includes potent topical corticosteroids for early lesions and intralesional corticosteroids injected into the active borders of established lesions. For inactive, atrophic lesions, topical steroids should be avoided as they may exacerbate the atrophy and increase the risk of new ulcerations."}
{"id": "article-25619_29", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "Ultraviolet (UV) light therapy is used for various inflammatory dermatoses. Psoralen and ultraviolet light A (PUVA) decreases the actively inflamed borders but has no clinical effects on atrophic scars.", "contents": "Necrobiosis Lipoidica -- Treatment / Management. Ultraviolet (UV) light therapy is used for various inflammatory dermatoses. Psoralen and ultraviolet light A (PUVA) decreases the actively inflamed borders but has no clinical effects on atrophic scars."}
{"id": "article-25619_30", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "Calcineurin inhibitors inhibit T-cell activation by blocking calcineurin resulting in both anti-inflammatory and immunomodulatory effects. Topical tacrolimus has been shown to be effective in resolving ulceration associated with necrobiosis lipoidica. [21] [22] [23]", "contents": "Necrobiosis Lipoidica -- Treatment / Management. Calcineurin inhibitors inhibit T-cell activation by blocking calcineurin resulting in both anti-inflammatory and immunomodulatory effects. Topical tacrolimus has been shown to be effective in resolving ulceration associated with necrobiosis lipoidica. [21] [22] [23]"}
{"id": "article-25619_31", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "TNF is an important regulator of the formation of granulomas. The monoclonal antibodies adalimumab and infliximab bind directly to soluble TNF-alpha to prevent its action. Etanercept is a fusion protein made up of the Fc portion of human IgG1 and TNF receptors that also inhibit TNF function. Both etanercept and infliximab have been repeatedly found to be effective as monotherapy for ulcerating necrobiosis lipoidica.", "contents": "Necrobiosis Lipoidica -- Treatment / Management. TNF is an important regulator of the formation of granulomas. The monoclonal antibodies adalimumab and infliximab bind directly to soluble TNF-alpha to prevent its action. Etanercept is a fusion protein made up of the Fc portion of human IgG1 and TNF receptors that also inhibit TNF function. Both etanercept and infliximab have been repeatedly found to be effective as monotherapy for ulcerating necrobiosis lipoidica."}
{"id": "article-25619_32", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "A study by Erfurt-Berge et al. found that topical steroids were predominantly used. Calcineurin inhibitors and phototherapy were the next most frequently used treatments. Systemically, fumarate esters were commonly employed, followed by steroids and dapsone. [24]", "contents": "Necrobiosis Lipoidica -- Treatment / Management. A study by Erfurt-Berge et al. found that topical steroids were predominantly used. Calcineurin inhibitors and phototherapy were the next most frequently used treatments. Systemically, fumarate esters were commonly employed, followed by steroids and dapsone. [24]"}
{"id": "article-25619_33", "title": "Necrobiosis Lipoidica -- Treatment / Management", "content": "Antiplatelet aggregation therapy with dipyridamole and aspirin has been tried based on the theory that necrobiosis lipoidica is due to platelet-mediated vascular occlusion or altered platelet survival. [25] The results of double-blind studies have been variable, but overall, some beneficial effects have been observed from the therapy.", "contents": "Necrobiosis Lipoidica -- Treatment / Management. Antiplatelet aggregation therapy with dipyridamole and aspirin has been tried based on the theory that necrobiosis lipoidica is due to platelet-mediated vascular occlusion or altered platelet survival. [25] The results of double-blind studies have been variable, but overall, some beneficial effects have been observed from the therapy."}
{"id": "article-25619_34", "title": "Necrobiosis Lipoidica -- Differential Diagnosis", "content": "The clinical presentation of necrobiosis lipoidica is distinct, but there are still many atypical appearances, and early\u00a0presentations can be hard to recognize. [26] The following are some important considerations: Acute complications of sarcoidosis Granuloma annulare Hematologic malignancies Paraproteinemia Rheumatoid arthritis Sarcoidosis Ulcerated necrobiotic Xanthogranuloma Xanthomas", "contents": "Necrobiosis Lipoidica -- Differential Diagnosis. The clinical presentation of necrobiosis lipoidica is distinct, but there are still many atypical appearances, and early\u00a0presentations can be hard to recognize. [26] The following are some important considerations: Acute complications of sarcoidosis Granuloma annulare Hematologic malignancies Paraproteinemia Rheumatoid arthritis Sarcoidosis Ulcerated necrobiotic Xanthogranuloma Xanthomas"}
{"id": "article-25619_35", "title": "Necrobiosis Lipoidica -- Prognosis", "content": "As the management of necrobiosis lipoidica is not very reassuring, its prognosis is also not very satisfactory. The disease is classically chronic, having variable progression. Squamous cell cancers\u00a0can be found\u00a0in more chronic lesions of necrobiosis lipoidica\u00a0associated with previous trauma and ulceration. [1]", "contents": "Necrobiosis Lipoidica -- Prognosis. As the management of necrobiosis lipoidica is not very reassuring, its prognosis is also not very satisfactory. The disease is classically chronic, having variable progression. Squamous cell cancers\u00a0can be found\u00a0in more chronic lesions of necrobiosis lipoidica\u00a0associated with previous trauma and ulceration. [1]"}
{"id": "article-25619_36", "title": "Necrobiosis Lipoidica -- Prognosis", "content": "From an aesthetic viewpoint, the prognosis of necrobiosis lipoidica is not reassuring. Treatment can help halt the expansion of lesions that tend to have a chronic course. Lesional ulcerations can result in significant morbidity, requiring\u00a0comprehensive wound care. These ulcers can be painful. They may become infected or heal with scarring.", "contents": "Necrobiosis Lipoidica -- Prognosis. From an aesthetic viewpoint, the prognosis of necrobiosis lipoidica is not reassuring. Treatment can help halt the expansion of lesions that tend to have a chronic course. Lesional ulcerations can result in significant morbidity, requiring\u00a0comprehensive wound care. These ulcers can be painful. They may become infected or heal with scarring."}
{"id": "article-25619_37", "title": "Necrobiosis Lipoidica -- Complications", "content": "Following are some complications of necrobiosis lipoidica: Long-term scarring Infection Sepsis Squamous cell cancer", "contents": "Necrobiosis Lipoidica -- Complications. Following are some complications of necrobiosis lipoidica: Long-term scarring Infection Sepsis Squamous cell cancer"}
{"id": "article-25619_38", "title": "Necrobiosis Lipoidica -- Deterrence and Patient Education", "content": "Patients suffering from diseases associated with necrobiosis lipoidica should be made aware of the clinical presentation of necrobiosis lipoidica so that as soon as the lesions begin, they may contact their primary care providers. This early presentation will help ensure a better prognosis. Patients should also be made aware of the drug treatments available and their possible adverse effects. Once they have an ulcer, they should be made knowledgeable about proper wound care in the community by the community wound nurses.", "contents": "Necrobiosis Lipoidica -- Deterrence and Patient Education. Patients suffering from diseases associated with necrobiosis lipoidica should be made aware of the clinical presentation of necrobiosis lipoidica so that as soon as the lesions begin, they may contact their primary care providers. This early presentation will help ensure a better prognosis. Patients should also be made aware of the drug treatments available and their possible adverse effects. Once they have an ulcer, they should be made knowledgeable about proper wound care in the community by the community wound nurses."}
{"id": "article-25619_39", "title": "Necrobiosis Lipoidica -- Deterrence and Patient Education", "content": "Ulcerative skin lesions may complicate the course of the disease, especially in patients with diabetes, but also in patients with arterial hypertension and/or\u00a0those who are overweight. There is no data to support any preventive measure for necrobiosis lipoidica.", "contents": "Necrobiosis Lipoidica -- Deterrence and Patient Education. Ulcerative skin lesions may complicate the course of the disease, especially in patients with diabetes, but also in patients with arterial hypertension and/or\u00a0those who are overweight. There is no data to support any preventive measure for necrobiosis lipoidica."}
{"id": "article-25619_40", "title": "Necrobiosis Lipoidica -- Enhancing Healthcare Team Outcomes", "content": "Necrobiosis lipoidica is a rare skin complication of type 1 diabetes. However, its diagnosis and management are exceedingly complex. The skin lesions are best managed with an interprofessional team that includes a dermatologist, endocrinologist, wound care nurse, internist, and infectious disease specialist. There is no specific treatment for NL. The key is to ensure that diabetes is well controlled. Open wounds and ulcers need to be managed by a wound care nurse. Many newer biological agents have been used to treat skin disorders, but without clinical trials, it is difficult to know the effectiveness of these agents. These patients need long-term follow-up as the wound closure can take months. Some people may benefit from compression therapy and stockings. [27]", "contents": "Necrobiosis Lipoidica -- Enhancing Healthcare Team Outcomes. Necrobiosis lipoidica is a rare skin complication of type 1 diabetes. However, its diagnosis and management are exceedingly complex. The skin lesions are best managed with an interprofessional team that includes a dermatologist, endocrinologist, wound care nurse, internist, and infectious disease specialist. There is no specific treatment for NL. The key is to ensure that diabetes is well controlled. Open wounds and ulcers need to be managed by a wound care nurse. Many newer biological agents have been used to treat skin disorders, but without clinical trials, it is difficult to know the effectiveness of these agents. These patients need long-term follow-up as the wound closure can take months. Some people may benefit from compression therapy and stockings. [27]"}
{"id": "article-25619_41", "title": "Necrobiosis Lipoidica -- Enhancing Healthcare Team Outcomes", "content": "All interprofessional healthcare team members must contribute from their area of expertise and maintain open communication channels with the rest of the team, particularly if the patient's condition deteriorates. Open communication also includes keeping accurate and updated patient records so that everyone involved in the case can access the same up-to-date patient data. With coordinated effort, cohesive action, and good interprofessional communication, these challenging cases will have their best chances for positive outcomes. [Level 5]", "contents": "Necrobiosis Lipoidica -- Enhancing Healthcare Team Outcomes. All interprofessional healthcare team members must contribute from their area of expertise and maintain open communication channels with the rest of the team, particularly if the patient's condition deteriorates. Open communication also includes keeping accurate and updated patient records so that everyone involved in the case can access the same up-to-date patient data. With coordinated effort, cohesive action, and good interprofessional communication, these challenging cases will have their best chances for positive outcomes. [Level 5]"}
{"id": "article-25619_42", "title": "Necrobiosis Lipoidica -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Necrobiosis Lipoidica -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}